Skip to content

Open Agenda September 2006

FUTURE COUNCIL MEETINGS
(Day 1–Closed Grant Review Open Policy Session Begins; Day 2–Open Policy Session Continues)
2007 2008
January 11–12 January 10–11
May 10–11 May 22–23
September 20–21 September 18–19

THURSDAY, SEPTEMBER 14

Neuroscience Center
6001 Executive Boulevard
First Floor, Conference Room C/D/E
Rockville, MD 20852

Time Event
4:00 p.m. CALL TO ORDER – Thomas R. Insel, M.D.
Director, NIMH
4:10–4:25 p.m. COUNCIL WORKGROUP ON MRI RESEARCH PRACTICES: FINAL REPORT
Presenter:
Jonathan D. Cohen, M.D., Ph.D.
Professor of Psychology
Director, Center for the Study of Brain, Mind and Behavior
Director, Program in Neuroscience
Princeton University
DISCUSSION
4:25–4:40 p.m. CONCEPT CLEARANCES
Presenters:
Thomas Lehner Ph.D., M.P.H.
Acting Director, Office of Human Genetics & Genomic Resources
Chief, Genetic Basis of Mental Disorders Program
Division of Neuroscience and Basic Behavioral Science, NIMH

David M. Stoff, Ph.D.
Program Chief: Neuropsychiatry of HIV/AIDS, AIDS Research Training, HIV/AIDS Health Disparities
Center for Mental Health Research on AIDS
Division of AIDS and Health and Behavior Research, NIMH
DISCUSSION
4:40–5:00 p.m. COUNCIL ISSUES
  • Helena C. Kraemer, Ph.D.—data sharing
    Professor, Department of Psychiatry and Behavioral Sciences
    Stanford University
  • Other Issues
DISCUSSION
5:00 p.m. ADJOURN (Session to resume on Friday, September 15, NIH Campus,
Building 31C, 6th floor, Conference Room 6)

FRIDAY, SEPTEMBER 15

Building 31C, 6th Floor, Conference Room 6
National Institutes of Health
9000 Rockville Pike
Bethesda, MD 20892

Time Event
8:30–8:35 a.m. CALL TO ORDER – Thomas R. Insel, M.D.
Director, National Institute of Mental Health (NIMH)
8:35–9:15 a.m. NIH AT THE CROSSROADS: STRATEGIES FOR THE FUTURE
Presenter:
Elias A. Zerhouni, M.D.
Director, NIH
DISCUSSION
9:15 a.m.–12:45 p.m. THE NIMH CLINICAL TRIALS PROGRAM: MAJOR FINDINGS AND IMPLICATIONS FOR EVERYDAY PRACTICE
9:15–9:30 a.m. Background and Context for the Program
Presenter:
Steven E. Hyman, M.D.
Provost, Harvard University
9:30–9:55 a.m. Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE)
Presenter:
Jeffrey Lieberman, M.D.
Director, New York State Psychiatric Institute
Chairman and Lieber Professor of Psychiatry
Department of Psychiatry
Columbia University Medical Center
DISCUSSION
9:55–10:20 a.m. Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
Presenter:
Gary Sachs, M.D.
Director, Bipolar Clinical and Research Program
Massachusetts General Hospital
Associate Professor of Psychiatry
Harvard Medical School
DISCUSSION
10:20–10:35 a.m. BREAK
10:35–11:00 a.m. Treatment for Adolescents with Depression Study (TADS)
Presenter:
John March, M.D., MPH
Professor of Psychiatry
Chief, Child and Adolescent Psychiatry
Department of Psychiatry and Behavioral Sciences
Duke University Medical Center
DISCUSSION
11:00–11:25 a.m. Sequenced Treatment Alternatives to Relieve Depression (STAR*D)
Presenter:
A. John Rush, M.D.
Vice Chair, Department of Clinical Sciences
Professor, Department of Psychiatry
Betty Jo Hay Distinguished Chair in Mental Health
Rosewood Corporation Chair in Biomedical Science
University of Texas Southwestern Medical Center at Dallas
DISCUSSION
11:25–11:40 a.m. Next Steps in Determining Optimal Care
Presenter:
Susan M. Essock, Ph.D.
Professor and Director
Division of Health Services Research
Mount Sinai School of Medicine
11:40–Noon DISCUSSANTS
  • Renata J. Henry
    Director, Division of Substance Abuse and Mental Health
    State of Delaware
  • Suzanne E. Vogel-Scibilia, M.D.
    Medical Director, Beaver County Psychiatric Service
Noon–12:45 p.m. Question-and-Answer Period
Moderator:
Thomas R. Insel, M.D.
12:45–1:00 p.m. PUBLIC COMMENTS
1:00 p.m. ADJOURN